Ana Garrido

850 total citations
26 papers, 324 citations indexed

About

Ana Garrido is a scholar working on Oncology, Hematology and Epidemiology. According to data from OpenAlex, Ana Garrido has authored 26 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Hematology and 7 papers in Epidemiology. Recurrent topics in Ana Garrido's work include Acute Myeloid Leukemia Research (7 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Polyomavirus and related diseases (3 papers). Ana Garrido is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Polyomavirus and related diseases (3 papers). Ana Garrido collaborates with scholars based in Spain, Portugal and United Kingdom. Ana Garrido's co-authors include Jorge Sierra, Rodrigo Martino, Albert Esquirol, Salut Brunet, Irene García‐Cadenas, Javier Briones, José M. Oliver, Silvana Novelli, Ana González and Ángel Serrano‐Aroca and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Thoracic and Cardiovascular Surgery and Pharmaceutics.

In The Last Decade

Ana Garrido

24 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ana Garrido Spain	12	117	98	73	62	52	26	324
Muhammad Ashar Ali United States	9	55 0.5×	73 0.7×	63 0.9×	48 0.8×	35 0.7×	41	298
Rita Balter Italy	12	92 0.8×	115 1.2×	29 0.4×	31 0.5×	66 1.3×	36	361
Nobuyuki Hyakuna Japan	11	148 1.3×	47 0.5×	90 1.2×	46 0.7×	20 0.4×	33	364
Michihiro Uchiyama Japan	9	276 2.4×	117 1.2×	56 0.8×	55 0.9×	56 1.1×	41	420
Shu-Huey Chen Taiwan	14	190 1.6×	97 1.0×	73 1.0×	32 0.5×	52 1.0×	29	426
Karen Mandel Canada	7	86 0.7×	73 0.7×	40 0.5×	31 0.5×	21 0.4×	13	280
Dimitrios Pikazis Greece	9	47 0.4×	66 0.7×	84 1.2×	51 0.8×	54 1.0×	20	349
Mariella D’Andrea Italy	9	216 1.8×	50 0.5×	57 0.8×	40 0.6×	21 0.4×	15	315
Blanca Molina Spain	11	178 1.5×	100 1.0×	44 0.6×	21 0.3×	32 0.6×	31	346
Takashi Fukuhara Japan	11	168 1.4×	39 0.4×	45 0.6×	30 0.5×	50 1.0×	40	302

Countries citing papers authored by Ana Garrido

Since Specialization

Citations

This map shows the geographic impact of Ana Garrido's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Garrido with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Garrido more than expected).

Fields of papers citing papers by Ana Garrido

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Garrido. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Garrido. The network helps show where Ana Garrido may publish in the future.

Co-authorship network of co-authors of Ana Garrido

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Garrido. A scholar is included among the top collaborators of Ana Garrido based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Garrido. Ana Garrido is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

García‐Cadenas, Irene, Albert Esquirol, Silvana Saavedra, et al.. (2025). Standard Versus Reduced‐Doses of Post‐Transplant Cyclophosphamide in HLA Matched (10/10) Peripheral Blood Stem Cell Transplantation. European Journal Of Haematology. 115(4). 413–422.

Vilar, Lúcio, Clarice Vilar, Ruy Lyra, et al.. (2024). Usefulness of prolactin levels in predicting the etiology of hyperprolactinemia in a cohort of 770 patients. Archives of Endocrinology and Metabolism. 68. e230391–e230391. 2 indexed citations

Fernández, Carlos Iglesias, et al.. (2024). Do the humeral radiographic changes at 5-year follow-up affect the clinical outcomes of press-fit humeral stems in primary reverse shoulder arthroplasties?. European Journal of Orthopaedic Surgery & Traumatology. 34(4). 1851–1863. 1 indexed citations

Pratcorona, Marta, Ana Garrido, Álex Bataller, et al.. (2023). Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort. Blood Cancer Journal. 13(1). 69–69. 9 indexed citations

Falgàs, Aïda, Naroa Serna, Laura Sánchez‐García, et al.. (2023). T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo. Pharmaceutics. 15(3). 727–727. 11 indexed citations

García‐Cadenas, Irene, Silvana Novelli, Silvana Saavedra, et al.. (2023). Successful Outcome in Patients with Myelofibrosis Undergoing Allogeneic Donor Hematopoietic Cell Transplantation Using Reduced Doses of Post-Transplantation Cyclophosphamide: Challenges and Review of the Literature. Transplantation and Cellular Therapy. 29(7). 473.e1–473.e6. 5 indexed citations

Garrido, Ana, et al.. (2022). 2022-RA-1237-ESGO Predictors of PARP inhibitors toxicities and the toxicity impact on overall survival in advanced ovarian cancer. International Journal of Gynecological Cancer. 32. A312–A312. 1 indexed citations

Bataller, Álex, Ana Garrido, Montserrat Hoyos, et al.. (2021). Prognostic impact of DNMT3A mutation in acute myeloid leukemia with mutated NPM1. Blood Advances. 6(3). 882–890. 19 indexed citations

Malinverni, Roberto, Joan Bargay, Blanca Xicoy, et al.. (2021). Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survival. Clinical Epigenetics. 13(1). 9–9. 23 indexed citations

10.

Novelli, Silvana, A Caballero, Ana Garrido, et al.. (2021). Efficacy and Safety of Ruxolitinib in Steroid-Refractory/Dependent Chronic Graft-versus-Host Disease: Real-World Data and Challenges. Transplantation and Cellular Therapy. 28(1). 43.e1–43.e5. 13 indexed citations

11.

Martino, Rodrigo, Ana Garrido, Irene García‐Cadenas, et al.. (2020). Low Rate of Invasive Fungal Infections During Induction and Consolidation Chemotherapy for Adults with De Novo Acute Myeloid Leukemia Without Anti-mold Prophylaxis: Single-Center 2002–2018 Empirical/Pre-emptive Approach. Mycopathologia. 185(4). 639–652. 2 indexed citations

12.

Garrido, Ana, Elena Bussaglia, Marta Pratcorona, et al.. (2019). Bone marrow WT1 levels in patients with myeloid neoplasms treated with 5‐azacytidine: Identification of responding patients. European Journal Of Haematology. 103(3). 208–214. 6 indexed citations

13.

García‐Cadenas, Irene, Albert Esquirol, Anna Bosch, et al.. (2019). Incorporating posttransplant cyclophosphamide-based prophylaxis as standard-of-care outside the haploidentical setting: challenges and review of the literature. Bone Marrow Transplantation. 55(6). 1041–1049. 14 indexed citations

14.

Garrido, Ana, et al.. (2019). Perforación de la pared del ventrículo izquierdo por catéter de arteria pulmonar Swan-Ganz. A propósito de un caso. Revista Española de Anestesiología y Reanimación. 66(10). 528–532. 3 indexed citations

15.

Barata, Anna, Rodrigo Martino, Ignasi Gich, et al.. (2017). Do Patients and Physicians Agree When They Assess Quality of Life?. Biology of Blood and Marrow Transplantation. 23(6). 1005–1010. 6 indexed citations

16.

Nomdedéu, Josep, Albert Esquirol, Marta Pratcorona, et al.. (2017). Bone Marrow WT1 Levels in Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplasia: Clinically Relevant Time Points and 100 Copies Threshold Value. Biology of Blood and Marrow Transplantation. 24(1). 55–63. 30 indexed citations

17.

García‐Cadenas, Irene, Rodrigo Martino, Pere Barba, et al.. (2015). Impact of Epstein Barr virus-related complications after high-risk allo-SCT in the era of pre-emptive rituximab. Bone Marrow Transplantation. 50(4). 579–584. 45 indexed citations

18.

Garrido, Ana, et al.. (2014). Pseudo-Bartter syndrome as an initial presentation of cystic fibrosis. Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT). 28(4). 348–351. 2 indexed citations

19.

Garrido, Ana, et al.. (2013). Serotonin Syndrome after Sertraline Overdose in a Child: A Case Report. SHILAP Revista de lepidopterología. 2013. 1–3. 15 indexed citations

20.

Oliver, José M., et al.. (2003). Rapid progression of midventricular obstruction in adults with double-chambered right ventricle. Journal of Thoracic and Cardiovascular Surgery. 126(3). 711–717. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact